AAP
AGN

Aristotle Atlantic Partners’s Allergan plc AGN Stock Holding History

Aristotle Atlantic Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12,500
Closed -$2.09M – 100
2019
Q2 		$2.09M Sell
12,500
-4,936
-28% -$683K 0.61% 31
2019
Q1 		$2.55M Buy
17,436
+1,117
+7% +$162K 0.78% 27
2018
Q4 		$2.18M Buy
16,319
+4,019
+33% +$659K 0.77% 27
2018
Q3 		$1.71M Sell
12,300
-5,855
-32% -$1.08M 1.05% 26
2018
Q2 		$3.02M Buy
18,155
+1,205
+7% +$193K 1.05% 23
2018
Q1 		$2.85M Buy
16,950
+1,780
+12% +$299K 1.03% 21
2017
Q4 		$2.48M Buy
+15,170
New +$2.72M 0.89% 26

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Aristotle Atlantic Partners's AGN Position: Q3 2019 in Review

Aristotle Atlantic Partners sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 12,500 shares — an estimated $2.09M sold.

Aristotle Atlantic Partners first reported a position in AGN in Q4 2017 and held it in 7 quarters. The position peaked at $3.02M in Q2 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Aristotle Atlantic Partners reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Aristotle Atlantic Partners sold 12,500 Allergan plc shares in Q3 2019, an estimated $2.09M.
  • Aristotle Atlantic Partners first reported a position in Allergan plc in Q4 2017 and held it in 7 quarters.
  • Aristotle Atlantic Partners's Allergan plc position peaked at $3.02M in Q2 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Aristotle Atlantic Partners's 13F filing for Q3 2019, filed 14 Nov 2019.